Commentary: Are methotrexate and azathioprine really equivalent for treating severe atopic eczema?

British Journal of Dermatology

Volumn 166, Issue 4, 2012, Pages 705-707

  Williams, H C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; FOLIC ACID; METHOTREXATE;

ATOPIC DERMATITIS; CLINICAL PRACTICE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 84859127814     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10873.x     Document Type: Note

References (10)

1. Patel AN, Langan SM, Batchelor JM,. A randomized trial of methotrexate vs. azathioprine for severe atopic eczema: a critical appraisal. Br J Dermatol 2012; 166: 701-04.
2. Schram ME, Roekevisch E, Leeflang MMG, et al. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol 2011; 128: 353-9.
3. Schram ME, Roekevisch E, Leeflang MMG, et al. Response to a randomized trial of methotrexate vs. azathioprine for severe atopic eczema: a critical appraisal. Br J Dermatol 2012; 166: 704-05.
4. Ormerod AD, Williams HC,. Compulsory registration of trials. Br J Dermatol 2005; 152: 859-60.
5. Piaggio G, Elbourne DR, Altman DG, et al. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006; 295: 1152-60.
6. Hopewell S, Clarke M, Moher D, et al. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med 2008; 5: e20.
7. Schram ME, Spuls PI, Leeflang MMG, et al. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy 2012; 67: 99-106.
8. Williams HC, Seed P,. Inadequate size of 'negative' clinical trials in dermatology. Br J Dermatol 1993; 128: 317-26.
9. Schmitt J, Schäkel K, Schmitt N, Meurer M,. Systemic treatment of severe atopic eczema: a systematic review. Acta Derm Venereol (Stockh) 2007; 87: 100-11.
10. Schmitt J, Langan S, Stamm T, Williams H, on behalf of the Harmonizing Outcome Measurements in Eczema (HOME) Delphi panel. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multi-perspective Delphi consensus process. J Invest Dermatol 2011; 131: 623-30.